Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice

Liver fibrosis is a disease caused by long‐term damage that is related to a number of factors. The current research on the treatment of liver fibrosis mainly focuses on the activation of hepatic stellate cell, in addition to protecting liver cells. byakangelicin has certain anti‐inflammatory ability...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Mol Med
Main Authors: Li, Xiaohe, Shao, Shuaibo, Li, Hailong, Bi, Zhun, Zhang, Shanshan, Wei, Yiying, Bai, Jiakun, Zhang, Ruotong, Ma, Xiaoyang, Ma, Bowei, Zhang, Liang, Xie, Chunfeng, Ning, Wen, Zhou, Honggang, Yang, Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412405/
https://ncbi.nlm.nih.gov/pubmed/32643868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados